| 0 (0%) | 02-21 14:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 23.24 | 1-year : | 27.14 |
| Resists | First : | 19.89 | Second : | 23.24 |
| Pivot price | 15.93  |
|||
| Supports | First : | 15.01 |
Second : | 12 |
| MAs | MA(5) : | 17.64 |
MA(20) : | 15.84 |
| MA(100) : | 11.19 |
MA(250) : | 9.81 |
|
| MACD | MACD : | 1.3 |
Signal : | 1 |
| %K %D | K(14,3) : | 84.3 |
D(3) : | 80.6 |
| RSI | RSI(14): 65.8  |
|||
| 52-week | High : | 19.89 | Low : | 5.19 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ STRO ] has closed below upper band by 7.6%. Bollinger Bands are 66.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 19.92 - 20.02 | 20.02 - 20.08 |
| Low: | 18.14 - 18.27 | 18.27 - 18.35 |
| Close: | 18.24 - 18.43 | 18.43 - 18.55 |
Sat, 21 Feb 2026
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Fri, 20 Feb 2026
Sell Signal: Is STRO stock a safe buy before earnings - Weekly Earnings Recap & AI Based Trade Execution Alerts - mfd.ru
Thu, 19 Feb 2026
Zealand Pharma AS (ZLDPF) Q4 2025 Earnings Call Highlights: Stro - GuruFocus
Thu, 19 Feb 2026
$STRO stock is up 12% today. Here's what we see in our data. - Quiver Quantitative
Thu, 19 Feb 2026
FDJ United (LFDJF) Full Year 2025 Earnings Call Highlights: Stro - GuruFocus
Thu, 12 Feb 2026
STRO: International growth and new tech partnerships drive improved annual EBITDA and recurring revenue - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 6.1e+006 (%) |
| Held by Institutions | 4.6 (%) |
| Shares Short | 560 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.2899e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | -205.2 % |
| Operating Margin | -401.4 % |
| Return on Assets (ttm) | -25.8 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | 1.0565e+008 % |
| Gross Profit (p.s.) | 9.01 |
| Sales Per Share | 529.41 |
| EBITDA (p.s.) | 9.43595e+007 |
| Qtrly Earnings Growth | -26 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -223 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.03 |
| Price to Cash Flow | -2.75 |
| Dividend | 0 |
| Forward Dividend | 528230 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|